Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical

Melissa M Daly1, Stella Doktor, Robert Flamm

  • 1Infectious Disease Research, Abbott Laboratories, Bldg. AP52, 200 Abbott Park Rd., Abbott Park, IL 60064, USA.

Insights

The msr(D) gene in Streptococcus pneumoniae, similar to Staphylococcus msr(A), can independently confer macrolide resistance. This efflux gene was prevalent in clinical isolates, particularly mef(A) in Europe.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Acquired macrolide resistance in Streptococcus pneumoniae is mediated by efflux genes, specifically mef(E) or mef(A).
  • These genes are often found on genetic elements that also contain a homologous open reading frame (ORF) to Staphylococcus msr(A), termed msr(D).

Purpose of the Study:

  • To evaluate the prevalence of mef(A/E) and the msr(D) gene in clinical isolates of Streptococcus pneumoniae.
  • To determine if the msr(D) gene alone can confer the macrolide efflux phenotype.

Main Methods:

  • Screening of 153 mef(+) Streptococcus pneumoniae clinical isolates from diverse global regions (1997-2002) using PCR for mef(A), mef(E), and msr(D).
  • Cloning of mef(A), mef(E), and msr(D) from resistant strains and transformation into a susceptible Streptococcus pneumoniae strain.
  • Testing antimicrobial susceptibilities and efflux pump induction in transformants.

Main Results:

  • The mef(A) gene was more frequently isolated in European isolates, with some presence in Canada.
  • The msr(D) gene was found to confer the macrolide efflux phenotype independently.
  • The study identified geographical variations in the prevalence of mef(A/E) genes.

Conclusions:

  • The msr(D) gene is a significant contributor to macrolide resistance in Streptococcus pneumoniae.
  • Understanding the distribution and function of these efflux genes is crucial for antimicrobial resistance surveillance.
  • Targeting these efflux mechanisms could be a strategy to combat macrolide-resistant Streptococcus pneumoniae infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...